A Multicenter Open-label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Investigate Efficacy, Safety and Pharmacokinetics after Dose Escalation in Japanese Subjects with Crohn's Disease - Trial 2015-004121-13
Access comprehensive clinical trial information for 2015-004121-13 through Pure Global AI's free database. This phase not specified trial is sponsored by AbbVie GK and is currently status unknown. The study focuses on Crohn's Disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2015-004121-13
Trial Details
EU Clinical Trials Register • 2015-004121-13
A Multicenter Open-label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Investigate Efficacy, Safety and Pharmacokinetics after Dose Escalation in Japanese Subjects with Crohn's Disease
Study Focus
Sponsor & Location
AbbVie GK
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Subject with suspicion of colitis other than Crohn's disease.
ICD-10 Classifications
Crohn disease, unspecified
Other Crohn disease
Crohn disease of large intestine
Crohn disease [regional enteritis]
Crohn disease of small intestine
Data Source
EU Clinical Trials Register
2015-004121-13
Non-Device Trial